The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Martin Haluzíková

Third Department of Medicine

First Faculty of Medicine

Charles University

Prague

Czech Republic

[email]@lf1.cuni.cz

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Third Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic. 1999 - 2012
  • Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, USA. 2004
  • 3 Medical Department, 1 Faculty of Medicine, Prague, Czech Republic. 1999 - 2000

References

  1. Preadipocyte factor-1 concentrations in patients with anorexia nervosa: the influence of partial realimentation. Kaválková, P., Dostálová, I., Haluzíková, D., Trachta, P., Hanušová, V., Lacinová, Z., Papežová, H., Domluvilová, D., Zikán, V., Haluzík, M. Physiol. Res (2012) [Pubmed]
  2. Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance. Kotulák, T., Drápalová, J., Kopecký, P., Lacinová, Z., Kramář, P., Ríha, H., Netuka, I., Malý, J., Housa, D., Bláha, J., Svačina, S., Haluzík, M. Physiol. Res (2011) [Pubmed]
  3. Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-alpha agonist treatment. Mráz, M., Lacinová, Z., Kaválková, P., Haluzíková, D., Trachta, P., Drápalová, J., Hanušová, V., Haluzík, M. Physiol. Res (2011) [Pubmed]
  4. Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation. Dostálová, I., Kaválková, P., Papezová, H., Domluvilová, D., Zikán, V., Haluzík, M. Nutr. Metab. (Lond) (2010) [Pubmed]
  5. The influence of obesity and different fat depots on adipose tissue gene expression and protein levels of cell adhesion molecules. Bosanská, L., Michalský, D., Lacinová, Z., Dostálová, I., Bártlová, M., Haluzíková, D., Matoulek, M., Kasalický, M., Haluzík, M. Physiol. Res (2010) [Pubmed]
  6. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome. Durovcová, V., Marek, J., Hána, V., Matoulek, M., Zikán, V., Haluzíková, D., Kaválková, P., Lacinová, Z., Kršek, M., Haluzík, M. Physiol. Res (2009) [Pubmed]
  7. PPAR-alpha and insulin sensitivity. Haluzík, M.M., Haluzík, M. Physiol. Res (2006) [Pubmed]
  8. The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Anderlová, K., Kremen, J., Dolezalová, R., Housová, J., Haluzíková, D., Kunesová, M., Haluzík, M. Physiol. Res (2006) [Pubmed]
  9. Adipocytokines and cancer. Housa, D., Housová, J., Vernerová, Z., Haluzík, M. Physiol. Res (2006) [Pubmed]
  10. The role of resistin in obesity-induced insulin resistance. Haluzik, M., Haluzikova, D. Curr. Opin. Investig. Drugs (2006) [Pubmed]
  11. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Haluzik, M.M., Lacinova, Z., Dolinkova, M., Haluzikova, D., Housa, D., Horinek, A., Vernerova, Z., Kumstyrova, T., Haluzik, M. Endocrinology (2006) [Pubmed]
  12. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. Housova, J., Anderlova, K., Krizová, J., Haluzikova, D., Kremen, J., Kumstyrová, T., Papezová, H., Haluzik, M. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  13. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance. Haluzik, M. Curr. Opin. Investig. Drugs (2005) [Pubmed]
  14. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies. Haluzik, M., Gavrilova, O., LeRoith, D. Endocrinology (2004) [Pubmed]
  15. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Haluzík, M., Parízková, J., Haluzík, M.M. Physiol. Res (2004) [Pubmed]
  16. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Haluzik, M., Colombo, C., Gavrilova, O., Chua, S., Wolf, N., Chen, M., Stannard, B., Dietz, K.R., Le Roith, D., Reitman, M.L. Endocrinology (2004) [Pubmed]
  17. Serum leptin levels in patients with hyperlipidemias. Haluzík, M., Fiedler, J., Nedvídková, J., Ceska, R. Nutrition (2000) [Pubmed]
  18. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Haluzík, M., Nedvídková, J. Physiol. Res (2000) [Pubmed]
  19. Treatment with the NO-synthase inhibitor, methylene blue, moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes. Haluzik, M., Nedvídková, J., Skrha, J. Endocr. Res. (1999) [Pubmed]
  20. Relationship of serum leptin levels and selected nutritional parameters in patients with protein-caloric malnutrition. Haluzík, M., Kábrt, J., Nedvídková, J., Svobodová, J., Kotrlíková, E., Papezová, H. Nutrition (1999) [Pubmed]
  21. Serum leptin concentrations in patients with combined hyperlipidemia: relationship to serum lipids and lipoproteins. Haluzík, M., Fiedler, J., Nedvídková, J., Ceska, R. Physiol. Res (1999) [Pubmed]
  22. The influence of methylene blue and L-NAME on the development of streptozotocin-induced diabetes in rats. Haluzík, M., Nedvídková, J., Skrha, J. Sb. Lek (1999) [Pubmed]
 
WikiGenes - Universities